MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajt.2026.08.003

Медицинская библиотека · American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026

Enhancing stability and function of induced regulatory T cells through membrane-anchored transforming growth factor-β1 and interleukin-10 secretion to protect against graft-vs-host disease.

Zhang Shuo, Li Ang, Li Xiangrong, Li Sen, Ji Xiang, Zhu Cuisong, Qiu Chenli, Zhang Xiaoyan, Xu Jianqing, Zhang Shuye

СтатьяПеревод в очереди

Аннотация

Graft-vs-host disease (GvHD) remains a key challenge in allogeneic transplantation, underscoring the need for effective therapies to establish immune tolerance. Adoptive regulatory T cell (Treg) therapy shows promise but is restricted by the limited expansion of natural Tregs (nTregs) and the instability of induced Tregs (iTregs). The latter are prone to losing forkhead box protein 3 expression and suppressive function in inflammatory microenvironments. Here, we developed membrane-anchored transforming growth factor-β1 (MAT) and interleukin (IL)-10 (IL-10)-secreting iTregs (MAT-iTregs), a novel engineered iTreg platform designed to enhance lineage stability and suppressive potency. MAT-iTregs express membrane-anchored transforming growth factor-β1 and produce high levels of interleukin-10 to amplify immunosuppression and maintain functional stability. We optimized construct design and manufacturing processes to yield highly enriched MAT-iTregs. In preclinical studies, MAT-iTregs outperformed conventional iTregs in safety profiles and therapeutic efficacy. MAT-iTregs significantly prolonged survival, reduced tissue injury, and attenuated pathogenic effector T cell responses in xenogeneic GvHD mice. Notably, MAT-iTregs maintained suppressive function, durable persistence, and a favorable safety profile in mouse models, with no evidence of converting to effector T cells and minimal tissue toxicity. Together, these findings support MAT-iTregs as a clinically translatable cell therapy to promote transplant tolerance and improve outcomes in GvHD.

Для цитирования: Zhang Shuo, Li Ang, Li Xiangrong, Li Sen, Ji Xiang, Zhu Cuisong, Qiu Chenli, Zhang Xiaoyan, Xu Jianqing, Zhang Shuye. Enhancing stability and function of induced regulatory T cells through membrane-anchored transforming growth factor-β1 and interleukin-10 secretion to protect against graft-vs-host disease.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2026. DOI: 10.1016/j.ajt.2026.08.003.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.